Education
About Us
Working with TipRanks
Follow Us
Love Pharma Inc (TSE:JOLT)
:JOLT
JOLT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.20
Previous CloseN/A
Volume0.00
Average Volume (3M)2.41K
Market Cap
C$572.79K
Enterprise ValueC$636.17K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.36
Next Earnings
Apr 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding6,364,377
10 Day Avg. Volume1,600
30 Day Avg. Volume2,412
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Love Pharma Inc News
JOLT FAQ
What was Love Pharma Inc’s price range in the past 12 months?
Love Pharma Inc lowest stock price was C$0.04 and its highest was C$0.20 in the past 12 months.
What is Love Pharma Inc’s market cap?
Love Pharma Inc’s market cap is C$572.79K.
When is Love Pharma Inc’s upcoming earnings report date?
Love Pharma Inc’s upcoming earnings report date is Apr 30, 2026 which is in 243 days.
How were Love Pharma Inc’s earnings last quarter?
Love Pharma Inc released its earnings results on Aug 28, 2025. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.
Is Love Pharma Inc overvalued?
According to Wall Street analysts Love Pharma Inc’s price is currently Overvalued.
Does Love Pharma Inc pay dividends?
Love Pharma Inc does not currently pay dividends.
What is Love Pharma Inc’s EPS estimate?
Love Pharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Love Pharma Inc have?
Love Pharma Inc has 6,364,377 shares outstanding.
What happened to Love Pharma Inc’s price movement after its last earnings report?
Love Pharma Inc reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Love Pharma Inc?
Currently, no hedge funds are holding shares in TSE:JOLT
Company Description
Love Pharma Inc
Glenbriar Technologies Inc offers cloud-enabled business technology solutions in Canada. The company operates through the Information Technology segment. It provides business technology solutions in manufacturing, distribution, retail, energy, health, professional services, and real estate. The company also provides IT outsourcing and consulting services. It derives the majority of its revenue from Managed information services.
Technical Analysis
Mydecine Innovations Group
―
Lifeist Wellness
―
Global Health Clinics
―
Lumiera Health Inc
―
NAVCO Pharmaceuticals Inc
―
Ownership Overview
14.68% Insiders
―
Mutual Funds
― Other Institutional Investors
85.32% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---